Objective. There is increasing knowledge of the pathophysiology behind inflammatory bowel
disease (IBD) although the exact mechanism is far from fully understood. In the era of new …

Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the bowel,
including ulcerative colitis and Crohn's disease. A single etiology has not been identified …

In recent years the use of faecal and serologic biomarkers has been evaluated in the
diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) …

Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …

Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of
biological and morphological tests. The current method of diagnostic remains a critical …

Introduction: Diagnosis of the chronic inflammatory bowel diseases relies upon initial
recognition of an inflammatory condition, followed by definitive endoscopic, histological and …

The role of biomarkers in the diagnosis of inflammatory bowel disease is not fully
characterized. C-reactive protein has a short half-life and elevates quickly after the onset of …

There is increasing importance placed upon noninvasive assessment of gut inflammation.
These tools are likely to be the key in differentiating intestinal inflammatory disease from …

Background: Inflammatory bowel disease (IBD) is a chronically relapsing disease with a
continuous need for proactive monitoring to decide appropriate treatments and follow-up …

Unambiguous diagnosis of the two main forms of inflammatory bowel diseases (IBD):
Ulcerative colitis (UC) and Crohn's disease (CD), represents a challenge in the early stages …